Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

pH-triggered microparticles for peptide vaccination.

W Nicholas Haining1, Daniel G Anderson, Steven R Little

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Pediatric Hematology/Oncology, Children's Hospital, Boston, MA 02115, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|August 6, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modular hydrogel system with independent control of bioadhesion, fibrosis, and stiffness.

Science advances·2026
Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026
Same author

Wireless battery-free oxygenation devices enable extended immunosuppression-free islet transplantation in minimally invasive sites.

Device·2026
Same author

The long noncoding RNA <i>lnc-FAM164A1</i>-ACLY axis promotes pro-inflammatory responses in human primary macrophages: a systems approach.

Frontiers in immunology·2026
Same author

Tuning the immune response to mRNA vaccines.

Nature biotechnology·2026
Same author

Therapeutic Spp1 silencing in TREM2<sup>+</sup> cardiac macrophages suppresses atrial fibrillation.

Nature cardiovascular research·2026

Novel pH-triggered microparticles enhance vaccine delivery to antigen-presenting cells (APCs), improving cytotoxic T lymphocyte (CTL) responses. This approach boosts antigen presentation for more effective CD8(+) T cell priming against viruses and cancer.

Area of Science:

  • Immunology
  • Vaccinology
  • Materials Science

Background:

  • Improving vaccine efficacy relies on enhancing antigen delivery to antigen-presenting cells (APCs).
  • Cross-presentation of antigens by APCs is crucial for initiating cytotoxic T lymphocyte (CTL) responses.
  • The phagosomal environment's low pH can be exploited for controlled antigen release.

Purpose of the Study:

  • To develop and evaluate pH-triggered microparticles for improved vaccine antigen delivery to APCs.
  • To assess the efficacy of these microparticles in enhancing antigen presentation and CTL priming.
  • To investigate the potential of pH-triggered microparticles for developing novel peptide vaccines.

Main Methods:

  • Encapsulation of a model MHC class I-restricted peptide antigen (Influenza A matrix protein) into spray-dried microparticles composed of dipalmitoylphosphatidylcholine and Eudragit E100.

Related Experiment Videos

  • Utilizing pH-sensitive Eudragit E100 for triggered peptide release in acidic phagosomal conditions.
  • Assessing microparticle phagocytosis, cellular toxicity, and functional impact on human monocytes and dendritic cells in vitro.
  • Evaluating peptide presentation to CD8(+) T cells by human dendritic cells and CTL priming in HLA-A*0201 transgenic mice.

    • Main Results:

    • pH-triggered microparticles efficiently phagocytosed by human APCs with minimal toxicity.
    • Superior presentation of encapsulated peptide to CD8(+) T cells by dendritic cells compared to unencapsulated or pH-insensitive encapsulated peptide.
    • Successful priming of CTL responses in vivo following vaccination with pH-triggered microparticle-encapsulated peptide.
    • Demonstrated potential for coencapsulation of antigens and adjuvants within the microparticles.

    Conclusions:

    • pH-triggered microparticles represent a promising strategy for enhancing vaccine antigen delivery and presentation.
    • This technology can improve CD8(+) T cell priming, offering potential for more effective peptide vaccines against viral infections and cancer.
    • The microparticle system's adaptability allows for the inclusion of various antigens and adjuvants for tailored vaccine development.